EGeen is a transatlantic CRO whose key business focus is to advance the drug development of biotech and pharmaceutical clients via expeditious and high quality yet cost-effective clinical trials.

Headquartered in California since its inception in 2001, EGeen has wholly owned subsidiaries in Estonia and Ukraine with operations in several Eastern European and Scandinavian countries. It was funded by premier US and international venture capital and private equity funds, and currently employs 50 people in the US and Europe in marketing, clinical trial management and monitoring, QA, logistics and IT support.

The key strengths of EGeen comprise its:

• Extensive network of hospitals and highly qualified medical doctors for rapid patient enrollment;
• Proprietary IT-driven medical and clinical data collection and management systems;
• International business and clinical standards combined with the local Eastern European operational expertise;
• Experienced clinical personnel and cost-effective infrastructure to efficiently manage clinical trials in all phases and major disease areas;
  
  
  • Particular focus and expertise in oncology, urology and CNS indications;
  • Additional expertise in most other major therapeutic areas;
  • Experiences and logistics support for biological and drug/device combination trials;